Nitric oxide synthases and cardiac muscle - Autocrine and paracrine influences

被引:203
作者
Balligand, JL
Cannon, PJ
机构
[1] COLUMBIA UNIV, COLL PHYS & SURG, DEPT MED, DIV CARDIOL, NEW YORK, NY 10032 USA
[2] UNIV LOUVAIN, SCH MED, DEPT MED, PHARMACOL UNIT, FATH 5349, BRUSSELS, BELGIUM
关键词
nitric oxide synthases; cardiac muscle; cytokines; heart failure;
D O I
10.1161/01.ATV.17.10.1846
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The different cell types comprising cardiac muscle express one or more of the three isoforms (neuronal NOS, or nNOS; inducible NOS, or iNOS; and endothelial NOS, or eNOS) of nitric oxide synthase (NOS). nNOS is expressed in orthosympathetic nerve terminals and regulates the release of catecholamines in the heart. eNOS constitutively expressed in endothelial cells inhibits contractile tone and the proliferation of underlying vascular smooth muscle cells, inhibits platelet aggregation and monocyte adhesion, promotes diastolic relaxation, and decreases O-2 consumption in cardiac muscle through paracrinally produced NO. eNOS is also constitutively expressed in cardiac myocytes from rodent and human species, where it autocrinally opposes the inotropic action of catecholamines after muscarinic cholinergic and beta-adrenergic receptor stimulation. iNOS gene transcription and protein expression are induced in all cell types after exposure to a variety of inflammatory cytokines. Aside from participating in the immune defense against intracellular microorganisms and viruses, the large amounts of NO produced autocrinally or paracrinally mediate the vasoplegia and myocardial depression characteristic of systemic immune stimulation and promote cell death through apoptosis. In cardiac myocytes, NO may regulate L-type calcium current and contraction through activation of cGMP-dependent protein kinase and cGMP-modulated phosphodiesterases. Other mechanisms independent of cGMP elevations may operate through interaction of NO with heme proteins, non-heme iron, or free thiol residues on target signaling proteins, enzymes, or ion channels. Given the multiplicity of NOS isoforms expressed in cardiac muscle and of the potential molecular targets for the NO produced, tight molecular regulation of NOS expression and activity at the transcriptional and posttranscriptional level appear to be needed to coordinate the many roles of NO in heart function in health and disease.
引用
收藏
页码:1846 / 1858
页数:13
相关论文
共 221 条
[11]  
BALLIGAND JL, 1994, J BIOL CHEM, V269, P27580
[12]   NITRIC OXIDE-DEPENDENT PARASYMPATHETIC SIGNALING IS DUE TO ACTIVATION OF CONSTITUTIVE ENDOTHELIAL (TYPE-III) NITRIC-OXIDE SYNTHASE IN CARDIAC MYOCYTES [J].
BALLIGAND, JL ;
KOBZIK, L ;
HAN, XQ ;
KAYE, DM ;
BELHASSEN, L ;
OHARA, DS ;
KELLY, RA ;
SMITH, TW ;
MICHEL, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14582-14586
[13]  
BALLIGAND JL, 1997, ENDOTHELIAL MODULATI, P53
[14]  
BALLIGAND JL, 1993, CIRCULATION S2, V88, P355
[15]   NITRIC-OXIDE AND PROSTACYCLIN - DIVERGENCE OF INHIBITORY EFFECTS ON MONOCYTE CHEMOTAXIS AND ADHESION TO ENDOTHELIUM INVITRO [J].
BATH, PMW ;
HASSALL, DG ;
GLADWIN, AM ;
PALMER, RMJ ;
MARTIN, JF .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02) :254-260
[16]   APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE [J].
BECKMAN, JS ;
BECKMAN, TW ;
CHEN, J ;
MARSHALL, PA ;
FREEMAN, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1620-1624
[17]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[18]   EXTENSIVE NITRATION OF PROTEIN TYROSINES IN HUMAN ATHEROSCLEROSIS DETECTED BY IMMUNOHISTOCHEMISTRY [J].
BECKMANN, JS ;
YE, YZ ;
ANDERSON, PG ;
CHEN, J ;
ACCAVITTI, MA ;
TARPEY, MM ;
WHITE, CR ;
BECKMAN, JS .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1994, 375 (02) :81-88
[19]   Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart - Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes [J].
Belhassen, L ;
Kelly, RA ;
Smith, TW ;
Balligand, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (08) :1908-1915
[20]   AN INHIBITOR OF MACROPHAGE ARGININE TRANSPORT AND NITRIC-OXIDE PRODUCTION (CNI-1493) PREVENTS ACUTE-INFLAMMATION AND ENDOTOXIN LETHALITY [J].
BIANCHI, M ;
ULRICH, P ;
BLOOM, O ;
MEISTRELL, M ;
ZIMMERMAN, GA ;
SCHMIDTMAYEROVA, H ;
BUKRINSKY, M ;
DONNELLEY, T ;
BUCALA, R ;
SHERRY, B ;
MANOGUE, KR ;
TORTOLANI, AJ ;
CERAMI, A ;
TRACEY, KJ .
MOLECULAR MEDICINE, 1995, 1 (03) :254-266